Kevin St P. McNaught
Department of Neurology
Mount Sinai School of Medicine
New York
New York 10029
USA
Name/email consistency: high
- The pattern of neuronal loss and survival may reflect differential expression of proteasome activators in Parkinson's disease. McNaught, K.S., Jnobaptiste, R., Jackson, T., Jengelley, T.A. Synapse (2010)
- Protein aggregation in the pathogenesis of familial and sporadic Parkinson's disease. McNaught, K.S., Olanow, C.W. Neurobiol. Aging (2006)
- Proteasomal dysfunction in sporadic Parkinson's disease. McNaught, K.S., Jackson, T., JnoBaptiste, R., Kapustin, A., Olanow, C.W. Neurology (2006)
- Proteasome inhibitor-induced model of Parkinson's disease. McNaught, K.S., Olanow, C.W. Ann. Neurol. (2006)
- Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease. McNaught, K.S., Perl, D.P., Brownell, A.L., Olanow, C.W. Ann. Neurol. (2004)
- Brainstem pathology in DYT1 primary torsion dystonia. McNaught, K.S., Kapustin, A., Jackson, T., Jengelley, T.A., Jnobaptiste, R., Shashidharan, P., Perl, D.P., Pasik, P., Olanow, C.W. Ann. Neurol. (2004)
- Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures. McNaught, K.S., Mytilineou, C., Jnobaptiste, R., Yabut, J., Shashidharan, P., Jennert, P., Olanow, C.W. J. Neurochem. (2002)
- Selective loss of 20S proteasome alpha-subunits in the substantia nigra pars compacta in Parkinson's disease. McNaught, K.S., Belizaire, R., Jenner, P., Olanow, C.W., Isacson, O. Neurosci. Lett. (2002)
- Aggresome-related biogenesis of Lewy bodies. McNaught, K.S., Shashidharan, P., Perl, D.P., Jenner, P., Olanow, C.W. Eur. J. Neurosci. (2002)